Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 51655-265

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 51655-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 265 26 Master Bottle Label Approval Rev A 06 20)

Label (51655 265 26 Master Bottle Label Approval   Rev A 06 20)
Sertraline Hydrochloride Tablets USP 50 mg film-coated tablets label. The container holds 90 tablets for oral use, labeled as prescription only. The label includes dosage instructions advising to see the package insert, storage conditions, and manufacturer information as Northwind Health Company, LLC. The label also displays the NDC code 51655-265-26.*
FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of sertraline hydrochloride, showing a bicyclic phenyl and cyclohexane ring system with two chlorine atoms and a methylamino group attached, consistent with the active ingredient sertraline hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.